In this work, we report a cost-effective supercontinuum (SC) laser-based multispectral photoacoustic spectroscopy (MSPAS) system for studying spectral characteristics of various analytes. We demonstrate an in vitro label-free monitoring of the analytes in the extended near-infrared (NIR) (1540-1840 nm) spectral range. We further demonstrate how a simple ratiometric analysis in conjunction with linear regression can be used for accurate prediction of glucose over commonly encountered physiological levels inside the human body (0-400 mg/dL). Looking forward, the proposed SC-based MSPAS system provides a framework for the development of label-free and non-invasive monitoring multiple bio-analytes accurately, with potential translation to clinical in vivo applications.
Accurate monitoring of bio-analytes inside the human body is of great interest for identification and diagnosis of various diseases. Glucose is one such bio-analytes, which is highly coveted for the interrogation of a fatal metabolic disorder known as Diabetes Mellitus (DM). An improper interrogation of DM would lead to the onset of severe chronic complications inside the human body 1 . Hence, several attempts are being made for devising reliable non-invasive and label-free techniques for the monitoring of glucose levels [2] [3] [4] . Photoacoustic spectroscopy (PAS) is capable of providing label-free information of the sample based on its endogenous contrast. PAS has attracted significant attention recently for studying various bio-analytes. Specifically, the mid-infrared region was widely employed for glucose detection due to the presence of fundamental absorption bands [5] [6] [7] [8] (9-11 um). However, the strong water absorption within this spectral region imposes significant limitations for non-invasive glucose measurements. Extended-NIR region provides promising abilities for devising label-free and non-invasive techniques for monitoring glucose, due to the presence of overtone and combination bands of C-H and O-H molecules which are present inside the glucose molecules. Therefore, established non-invasive monitoring techniques are mostly based on commercially available monochromatic laser systems in extended-NIR [9] [10] [11] . However, since the absorption of glucose has similar characteristics to that of other bio-analytes (like water and cholesterol), the monochromatic based monitoring techniques have limited sensitivity [12] [13] [14] [15] [16] . SC lasers offer an attractive all-fiber alternative to generate broadband emission from ultra violet (UV) to mid infrared region (MIR) of electromagnetic spectrum [17] [18] [19] . For this goal, we present a method to accurately measure glucose concentrations in vitro using an SC-based MSPAS system. The proposed method is based on a two-step approach; initially, the spectral characteristics of the bio-analytes are established in the complete wavelength region of interest using a home-built tunable laser system (1540-1840 nm). We then apply a ratiometric analysis at the wavelength, where glucose shows higher absorption contrast with respect to the other bio-analytes, thereby enabling accurate concentrations.
EXPERIMENTAL SETUP:
Figure 1 shows a schematic of the MSPAS system used for both the characterization of glucose spectra and the glucose concentration experiments. The system employs a home-built SC laser in conjunction with a linear variable filter (LVF) as the tunable excitation source. The output from the laser can be tuned from 1500-1900 nm. However, the bandwidth of the filtered light is limited to the LVF (2% of the excitation wavelength). The filtered light from the source is collimated using an aspheric lens (L1), steered using a mirror (M1) and then focused into the sample solution (about 5 mm above the surface of the sample holder) using an objective lens (L2).
Figure 1: Schematic of the MSPAS system. A home-built SC laser in conjunction with the LVF is used as optical excitation source; the output from the laser is collimated using a lens (L1) and then focused inside the sample solution using an objective lens (L2). The generated PA signals are detected using a focused transducer, amplified using a low-noise amplifier then sent for further data processing. The inset shows the recorded PA signal and its computed envelope signal.
The generated PA signal is detected using a commercial 7.5 MHz ultrasonic focused transducer. The detected signals are then filtered by a low pass filter, amplified using two cascaded low-noise wideband signal amplifiers and are then further processed. The samples of glucose solutions were prepared by dissolving different proportions of glucose weighed using a sensitive balance (0-400 mg in steps of 50 mg) and are then dissolved in the distilled water.
RESULTS AND DISCUSSIONS:
In order to accurately monitor a bio-analyte like glucose using PAS, it is very important to first establish its absorption characteristics, as the PA amplitude of the analyte depends on its absorption properties. To establish the absorption characteristics of the glucose in the extended-NIR, the PA amplitudes of the glucose were recorded from 1540-1840 nm in steps of 20 nm. The PA amplitude at a known concentration is given by,
The PA spectrum shows a peak at 1620 nm, which can be attributed to the increased absorption due to the overtone and combination band in the extended-NIR. Similar absorption characteristics were revealed from the measurements of commercial Fourier transform infrared (FTIR) spectrometer. Figure 2(b) is the absorption spectrum of D-glucose measured using FTIR system. To show the capability of the MSPAS system for label-free bio-analyte monitoring applications, the PA amplitudes of different glucose concentrations varying from 0-400 mg/dL (physiological glucose concentrations inside the human body) in steps of 50 mg/dL were recorded (0 mg/dL is pure distilled water). Figure 3 presents the variation of PA amplitude with respect to the concentration of the glucose in the test solution. It can be clearly observed that the PA amplitude variation shows a close to linear correlation, as the increase in the concentration of glucose in the test solution increases the overall absorption, thereby increasing the detected PA amplitude. The computed coefficient of determination (R 2 ) of the variation is found to be 0.938. To further explore the potential of the current MSPAS system for clinical applications, 22 random concentrations of test glucose solutions were prepared and their PA amplitudes were recorded so as to predict the concentration of glucose inside the test glucose solution. The detailed background about the prediction of glucose is described in our previous study 16 . Figure 4 shows the variation of predicted glucose concentration as a function of the reference glucose concentration for 22 random test solutions, ranging over the commonly encountered physiological concentrations inside the human body. A linear regression 16 applied to the predicted data set yields a coefficient of determination (R 2 ) of 0.912. Thus showcasing the potential of the current system towards accurate and label-free monitoring applications.
CONCLUSION:
In summary, we reported the development of the MSPAS system based on a home-built SC laser. We then employed the MSPAS system for identifying the absorption characteristics of glucose. We demonstrated how the proposed system can be used to measure glucose concentration using ratiometric analysis over physiological concentrations commonly encountered inside the human body. Using linear regression analysis we further demonstrated that glucose concentrations can be determined for clinical applications with sufficient accuracy (coefficient of determination of 0.912).
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